InsidersTradesSigma
Follow the 레메디 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). The latest transaction was disclosed on 16 July 2026 (Purchase). Among the most active insiders: 조봉호. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
레메디 is a company listed on the XKRX market. It specializes in the health and biotechnology sector.